In vivo assessment of antimicrobial activity and toxicity of repeated 1% povidone-iodine applications versus a single 5% povidone-iodine application

Author:

Teren David1ORCID,Neuman Gil1ORCID,Abulafia Adi1ORCID,Gelman Evgeny1ORCID,Assayag Elishai1ORCID,Hajj Abeer2,Shwartz Orna2,Zadok David1ORCID

Affiliation:

1. Department of Ophthalmology, Shaare Zedek Medical Center, affiliated with the Hebrew University, Hadassah School of Medicine, Jerusalem, Israel.

2. Microbiology and Immunology Laboratory, Wolfson Medical Center, Holon, Israel.

Abstract

Purpose: To demonstrate the non-inferiority in antimicrobial effectiveness of thrice-repeated applications of 1% povidone-iodine (PI) compared to a single application of 5% PI on the ocular surface in vivo and to evaluate potential toxicity of PI to the corneal epithelium. Setting: Department of Ophthalmology, Shaare Zedek Medical Center, Jerusalem, Israel. Design: Prospective randomized, double-blind study. Methods: Patients randomly received either a single application of 5% PI or repeated irrigations of 1% PI on the ocular surface before surgery. Bacterial colony counts were quantitatively analyzed by taking standardized conjunctival swabs before and after irrigation, and differences in bacterial colony counts were compared between the 2 groups. The presence of superficial punctate keratopathy was evaluated in all patients by the National Eye Institute grading system. Results: The study comprised 102 eyes of 102 patients. Both 1% and 5% PI yielded a marked decrease in bacterial colonies compared to pre-application (P<.001). The repeated application of 1% PI showed a significantly lower bacterial count compared to the single application of 5% PI (P<.05) and resulted in significantly less damage to the corneal epithelium compared to a single 5% PI application (P<.001). Conclusion: Preoperative repeated applications of 1% PI effectively eradicated ocular surface bacteria equal to that of 5% PI with less deleterious impact on the corneal epithelium. Our findings suggest that 1% PI may be a promising alternative to 5% PI.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3